• Bardoxolone Methyl Continues to Aid Alport Patients with Kidney Disease, New Data Shows
  • NIH Agency Pioneers Collaborative Research into Rare Diseases
  • Researchers Find Potential Therapeutic Target for Alport Syndrome in Mouse Study
  • New System Proposed for Classifying Collagen IV Gene Disorders as Types of Alport
  • Genome Sequencing and Its Clinical Potential Focus of NYC Rare Disease Day Event
  • Screening Test Raises Possibility of Therapeutic Approach for Alport Syndrome
  • Alport Syndrome Case Study Shows Unusual Transition in Boy’s Kidney
  • ‘A Disease May Be Rare, Hope Should Never Be,’ Says Boy with SMARD at Connecticut Rare Disease Day Event
  • Tailored Chemo Doses Proved Successful for Alport Patient with Breast Cancer in Case Report
  • Rare Disease Groups Welcome FDA’s Embrace of ‘Real World’ Data in Clinical Trials
  • Scientists Develop Better Way to Assess Alport-related Molecule’s Formation
  • US Lawmakers Urge Bipartisan Support for Rare Disease Research, Patients’ Needs